Maestrano Group – really on the right track now
A change of direction for the innovative little company could herald a lucrative future for investors, writes Mark Watson-Mitchell.
A change of direction for the innovative little company could herald a lucrative future for investors, writes Mark Watson-Mitchell.
Robert Stephens, CFA, discusses the investment appeal of two FTSE 250-listed housebuilders – Bellway and Redrow.
This international provider of business information, training and specialist consultancy services has some big expansion plans in hand, writes Mark Watson-Mitchell.
Veteran mining analyst John Cornford reviews some of the more interesting plays in the junior mining sector…
In this weekly summary, Mark Watson-Mitchell updates his readers on previous company profiles and other news of interest from the exciting world of small cap stocks…
In this weekly summary, Mark Watson-Mitchell updates his readers on previous company profiles and other news of interest from the exciting world of small cap stocks…
Bill Blain presents some ideas on how investment imperatives have to adapt as the underlying narrative changes.
Toronto-based Portage BioTech is preparing to commence trading on the NASDAQ tomorrow using the symbol PRTG.
Robert Stephens discusses the prospects for two FTSE 100 shares that have experienced disruption due to Covid-19.
Mark Watson-Mitchell considers what’s going on at this AIM-listed communication technology business.